Esperion Acquires Enbumyst Maker Corstasis

Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares are down during Tuesday’s premarket session as the company announced a definitive agreement to acquire Corstasis Therapeutics. This news comes as broader markets experienced declines, with major indices like the S&P...